Is your workstation working against you? georgeherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from georgeherald.com Daily Mail and Mail on Sunday newspapers.
Company reaches next clinical trial milestone for the intramuscular treatment of Chronic Lower Back Pain with the first novel allogenic cellular therapy in the United States
PHOENIX, Oct. 10, 2023.
Biotechnology company Creative Medical Technology Holdings, Inc. (CELZ) announced Tuesday that it has received Institutional Review Board (IRB) approval to proceed with its clinical trial for the treatment of chronic lower back pain with its StemSpine procedure using AlloStem (CELZ-201-DDT) cell therapy.
Creative Medical Technology Holdings, Inc. announced that it has received Institutional Review Board approval to proceed with its clinical trial for the treatment of chronic lower back pain with its.
Degenerative Disc Disease Clinical Trial Pipeline Insights | 15+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.